BioVie Inc. Prepaid Expense and Other Assets, Current
BioVie Inc. (BIVI) had Prepaid Expense and Other Assets, Current of $1.61 million as of 2026-03-31, per its S-1/A filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.61M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $873.88K.
- 2025-06-30: Prepaid Expense and Other Assets, Current $1.05M.
- 2025-03-31: Prepaid Expense and Other Assets, Current $569.53K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-03-31 | $1.61M S-1/A · filed 2026-08-06 |
| 2025-09-30 | $873.88K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.05M S-1/A · filed 2026-08-06 |
| 2025-03-31 | $569.53K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $275.83K 10-Q · filed 2025-02-11 |
| 2024-06-30 | $204.39K S-1/A · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |